Single dose oral pharmacokinetic profile of α-mangostin in mice

Current Drug Targets

Volumn 13, Issue 14, 2012, Pages 1698-1704

  Ramaiya, Atulkumar ^a   Li, Gongbo ^a   Petiwala, Sakina M ^a   Johnson, Jeremy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

mangostin; Absorption; Mangosteen; Pharmacokinetics; Reference:; Xanthone

Indexed keywords

ALPHA MANGOSTIN; UNCLASSIFIED DRUG; XANTHENE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; EQUIPMENT; GARCINIA MANGOSTANA; HEMATOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION STUDY;

ADMINISTRATION, ORAL; ANIMALS; GARCINIA MANGOSTANA; HUMANS; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; XANTHONES;

EID: 84876729768     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012804545524     Document Type: Article

References (16)

1. Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res 2009; 23: 1047-65.
2. Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol 2008; 46: 3227-39.
3. Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007; 21: 336-9.
4. Li L, Brunner I, Han AR, Hamburger M, et al. Pharmacokinetics of alpha-mangostin in rats after intravenous and oral application. Mol Nutr Food Res 2011; 55 Suppl 1: S67-74.
5. Syamsudin, Faizatun, Rahayu L. HPLC analysis and pharmacokinetic study of mangostin after oral administration in rats. T Pharma Res 2009; 2: 43-49.
6. Udani JK, Singh BB, Barrett ML, Singh VJ. Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study. Nutr J 2009; 8: 48.
7. Johnson JJ, Syed DN, Suh Y, Heren CR, et al. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 2010; 3: 1112-23.
8. Johnson JJ. Carnosol: a promising anti-cancer and antiinflammatory agent. Cancer Lett 2011; 305: 1-7.
9. Johnson JJ and Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett 2007; 255: 170-81.
10. Johnson JJ, Bailey HH, Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010; 17: 3-13.
11. Boocock DJ, Faust GE, Patel KR, Schinas AM, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007; 16: 1246-52.
12. Chow HH, Garland LL, Hsu CH, Vining DR, et al. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila) 2010; 3: 1168-75.
13. Johnson JJ, Petiwala SM, Syed DN, et al. alpha-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis, 2012.
14. Radcliffe JD, Czajka-Narins DM. Lipids and tocopherols in serum and liver of female rats fed diets containing corn oil or cottonseed oil. Plant Foods Hum Nutr 2006; 61: 35-8.
15. Bumrungpert A, Kalpravidh RW, Suksamrarn S, et al. Bioaccessibility, biotransformation, and transport of alphamangostin from Garcinia mangostana (Mangosteen) using simulated digestion and Caco-2 human intestinal cells. Mol Nutr Food Res 2009; 53 Suppl 1: S54-61.
16. Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011; 55: 1169-76.